Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 10:02 PM
Study NCT ID:
NCT01133158
Status:
COMPLETED
Last Update Posted:
2018-11-01
First Post:
2010-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial
Sponsor:
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-11
First Submit QC Date:
None
Study First Post Date:
2010-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-07
Results First Submit QC Date:
None
Results First Post Date:
2018-11-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-21
Last Update Post Date:
2018-11-01
Last Update Post Date Type:
ACTUAL